Related by context. Frequent words. (Click for all words.) 63 commercializing therapeutic 63 oncology anti infective 62 inflammation autoimmune diseases 61 commercializes biotherapeutics 61 addressing idiopathic pulmonary 61 BioMarin develops 60 commercializes innovative biopharmaceuticals 60 fibrosis IPF 60 inflammatory autoimmune 59 commercializes proprietary 59 novel antibody therapeutics 58 cardiovascular metabolic 57 IV pumps Pyxis 57 Connetics Corporation 57 commercializes innovative 57 unique PER.C6 ® 56 immunologic diseases 56 autoimmune inflammatory 56 Inc. NASDAQ CRIS 55 Fresenius Kabi AG 55 please visit http:/www.supergen.com 55 R bortezomib 55 CA Somaxon Pharmaceuticals 54 endocrine diseases 54 oncology neurology 54 developing Zerenex TM 54 commercializing novel 54 anti infective 54 Novelos Therapeutics Inc. 53 novel RNAi therapeutics 53 commercializing proprietary 53 immunology disorders 53 Tissue Repair Company 53 small molecule therapeutics 53 NovaBay Pharmaceuticals Inc. 53 Vitesse designs 53 human antibody therapeutics 53 orthobiologic 53 cancer immunotherapies 52 Inc. Nasdaq IMGN 52 silver dihydrogen citrate 52 therapeutic monoclonal antibodies 52 Adnexus Therapeutics 52 Cerus Corporation 52 Initiates Phase II 52 Inc Therapeutic Competitors 52 BioSilicon TM 52 Atrigel 51 Genaera Corporation 51 called lipopeptides 51 Focused solely 51 QUALCOMM Incorporated www.qualcomm.com 51 Neurogen Corporation 51 Adeona Pharmaceuticals Inc. 51 chemical entities NCEs 51 ImmuneRegen BioSciences Inc. 51 www.pozen.com 51 bio therapeutics 51 PEGylation technology 50 New Chemical Entities 50 NovaBay Pharmaceuticals 50 www.combinatorx.com 50 Inc. NASDAQ TRGT 50 Merck discovers develops 50 immunotherapeutics 50 visit www.PAREXEL.com 50 Chemokine Therapeutics 50 oncology therapeutics 50 By JOSHUA WOLFSON 50 Ligand proprietary 50 Completes Enrollment 50 Pharsight Corporation 49 Presents Positive 49 aesthetic dermatology 49 OSI Prosidion 49 develops acquires 49 Joseph Levi Esq 49 commercializes innovative therapeutics 49 Paris EURONEXT SAN 49 KemPharm 49 GEM #S 49 commercializes novel 49 Kensey Nash Corporation 49 NASDAQ CRXL 49 Transcept Pharmaceuticals 49 Nasdaq ALTH 49 www.syntapharma.com 49 Imagine Dateline NBC 49 Hybridon 49 Mersana 49 cardiovascular stents 49 biopharmaceuticals 48 By Thomas Gryta 48 Inc. NASDAQ RRGB 48 By Neil Osterweil 48 virosome adjuvanted vaccine 48 Ceragenix Pharmaceuticals Inc. 48 NASDAQ DYAX 48 By MusicRooms 48 ocular diseases 48 immunodiagnostics